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Trial QAa b s t r a c t
Background and purpose: Hypofractionated bladder RT with or without image guided adaptive planning
(HYBRID) is a multicentre clinical trial investigating ‘‘Plan of the Day” (PoD) adaptive radiotherapy for
bladder cancer. To ensure correct PoD selection a pre-accrual guidance and assessment module was
developed as part of an image guided radiotherapy quality assurance (IGRT QA) credentialing pro-
gramme. This study aimed to evaluate its feasibility and effectiveness across multiple recruiting centres.
Materials and methods: Individuals from participating centres remotely accessed an image database in
order to complete the PoD module. An assessment score of 83% was required in order to receive QA
approval. A questionnaire was used to gather user feedback on the module. PoD decisions for the first
patient at each recruiting centre were retrospectively reviewed for protocol adherence.
Results: 71 radiation therapists (RTTs) from 10 centres completed the PoD module. The median assess-
ment score was 92% (Range: 58–100%) with 79% of RTTs passing the assessment on first attempt. All
questionnaire respondents reported that the PoD module prepared them for plan selection. In 51/60 of
on-trial treatments reviewed, the PoD selected by the centre agreed with QA reviewers.
Conclusions: The PoD QA module was successfully implemented in a multicentre trial and enabled pre-
accrual assessment of protocol understanding. This increased operator confidence and resulted in appro-
priate PoD selection on-trial.
Crown Copyright  2019 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and
Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction rigorous quality assurance (QA) program of the IGRT component ofImage guided radiotherapy (IGRT) and adaptive RT are increas-
ingly employed with modern external beam radiotherapy (RT) to
ensure the accurate delivery of treatment. When implementing
new IGRT techniques it is critical to ensure that this is undertaken
is a safe and effective manner. This is especially important in the
clinical trial setting when the trial involves the introduction of
novel image guidance techniques to a recruiting centre, for which
there may not be a standard departmental procedure. Delivery of athese adaptive RT trials is essential to maintain patient safety and
ensure integrity of the trial data [1].
An initial step is to collect sufficient documentation relating to
the imaging technique and tolerances for setup correction used by
each centre and ensure these meet both national recommenda-
tions and minimum trial specifications. Locally developed pro-
grammes, including anatomical site specific competency
assessments, are reviewed as part of the QA process to ensure that
Radiation Therapists/Therapeutic Radiographers (RTTs) correctly
implement IGRT within the trial [1]. Ensuring the quality of these
processes and training at multiple sites remains a challenge for tri-
als quality assurance teams.
Hypofractionated bladder RT with or without image guided
adaptive planning (HYBRID; CRUK/12/055), is a randomised
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of-the-day (PoD) trial undertaken in the United Kingdom [2]. The
POD approach utilises volumetric image guidance with cone-
beam computed tomography (CBCT) to select the most appropriate
prepared plan for that patient on a daily basis and this is suggested
to be one of the commonest adaptivemethods in bladder radiother-
apy [3,4]. Adaptive RT trials utilising a PoD concept present a signif-
icant challenge when designing a trial QA programme. The role of
IGRT in these trials is extended beyond confirming accurate patient
set-up to active treatment decisionmaking through soft tissue eval-
uation, in order to choose an optimal plan which encompasses the
treatment volume and minimises dose to organs at risk (OAR) [1].
Such trials are likely to have endpoints, which directly link to accu-
racy of plan selection, for example toxicity, hence prospective
assessment of protocol compliance and individual staff member’s
competency is a critical element of the trial QA. A suitable QA pro-
gramme must be applicable for all participating centres and allow
for multi-vendor delivery equipment.
Several single centre studies have reported on the training and
assessment of RT staff for adaptive bladder PoD selection [5–8].
Whilst workshop based training has been utilised effectively for
these studies it is not considered practical in a larger multi-
centre trial setting. A multi-centre adaptive bladder trial under-
taken by the Trans-Tasman Radiation Oncology Group, utilised a
series of web-based e-learning modules to improve knowledge of
anatomy, treatment imaging and protocol requirements [9]. This
web based platform was well received and utilised by many RT
staff however a need for pre-accrual practical IGRT experience
was expressed by a number of centres [10].
Against this background, a pre-accrual guidance and assess-
ment module for adaptive plan selection in bladder RT was devel-
oped as part of an IGRT QA credentialing programme for the
HYBRID trial. This module utilised a novel approach by providing
RTTs practical hands-on experience selecting the PoD with bladder
CBCT images prior to trial recruitment. The primary study aim was
to evaluate the feasibility of implementing a pre-accrual PoD guid-
ance and assessment module in a multi-vendor, multi-centre trial
setting. A secondary aim was to analyse the effectiveness of the
module with regard to improving operator knowledge and confi-
dence when selecting the PoD for HYBRID.2. Materials and methods
HYBRID is a phase II multicentre randomised trial which fol-
lowed a single centre pilot study (APPLY). HYBRID recruited 65
patients across 10 participating RT centres and completed recruit-
ment in August 2016 [2]. Trial participants were randomised
between standard and adaptive RT treatment and received a dose
of 36 Gy delivered in six fractions over six weeks. Participants ran-
domised to the standard arm had a single RT plan covering the PTV,
which was expanded from the empty whole bladder CTV using a
standard isotropic margin. For those randomised to the adaptive
arm, three PTVs (small, medium and large) were generated from
a single empty bladder CTV using anisotropic population based
expansions [11]. Three plans were then produced to cover the
varying PTV sizes. For all patients a CBCT was acquired before each
RT treatment and for the adaptive arm the most appropriate plan
chosen to cover the entire bladder volume and minimise dose to
surrounding OAR.Fig. 1. Screen shots illustrating female (top) and male (bottom) assessment cases.2.1. HYBRID QA programme
The National Radiotherapy Trials Quality Assurance (RTTQA)
group worked in collaboration with the HYBRID Trial Management
Group to define the expectations of the treatment plan selectionand develop an appropriate QA programme consisting of pre-
accrual and during accrual components. Centres wishing to partic-
ipate in HYBRID completed a facility questionnaire which captured
their experience with volumetric bladder IGRT and a process doc-
ument to detail the adaptive patient pathways within their own
department. Pre-accrual outlining and planning benchmark cases
were also undertaken, which is standard practice for most RT trial
QA programmes.
An IGRT credentialing programme was designed in order to
prospectively assess RTT competency with PoD selection for
HYBRID. This included a pre-accrual PoD guidance and assessment
module, a centre visit for the first adaptive patient recruited from
each centre and retrospective review of PoD decisions for all
recruited patients.
2.2. PoD guidance and assessment module
The objective was to provide a vendor specific PoD guidance
and assessment package to be accessed remotely by RTTs geo-
graphically spread across the UK. Therefore, two vendor specific
image databases were setup with five sets of anonymised patient
data each consisting of one planning CT and 6 CBCT scans from
the pilot study, APPLY [7]. A web based approach to viewing and
registration of image data enabled individual rather than centre
credentialing and gave RTTs pre-accrual hands on experience with
selecting the appropriate PoD. A multi-disciplinary working party
consisting of clinicians and RTTs was established to choose the ‘‘ex-
pert consensus answers” for the guidance and assessment cases.
Three sets of data in the image databases were used as guidance
cases with the appropriate PoD selection, rationale and screenshots
provided in an accompanying guidance document (Fig. 1). RTTs
were able to register and manipulate the planning CT with each
of the CBCTs as they would do for treatment verifications, to build
confidence in both the plan selection and protocol requirements.
The remaining two sets of data in the image databases, one female
and one male case were used for the PoD assessment.
For the PoD assessment process, RTTs were asked to indepen-
dently register the 12 CBCT images using the trial protocol, and
adjust the image registration as necessary to include the bladder
volume within the smallest possible PTV contour from the three
available plans. The protocol specified the requirement for a
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PoD selections for each case were recorded and submitted to
RTTQA for review.
A minimum pass mark of 10/12 (83%) with the ‘‘expert con-
sensus answers” was necessary in order to pass the pre-accrual
PoD assessment. The minimum pass mark was selected based on
the 80% pass mark suggested by McNair et al following the PoD
training and assessment of staff members at a single centre [6].
Only those staff members who had successfully completed the
assessment were approved to undertake plan selection for HYBRID.
Recruiting centres were responsible for ensuring that individuals
maintained their competency through involvement with, or retro-
spective review of any recruited patients.
2.3. Data analysis
The individual assessment scores were reviewed and analysed
with descriptive statistics. Median assessment scores for the
female and male case was compared using Wilcoxon signed rank
test. Assessment results were also analysed according to staff
‘‘Agenda for change” (AFC) UK banding systems with staff ranging
from Band 5 (junior) to Band 8 (management). The Kruskal-Wallis
test was used to compare the assessment scores for each AFC band.
2.4. Online questionnaire
An online questionnaire was circulated to the IGRT RTTQA lead
at each trial centres to obtain information regarding theirTable 1
Hybrid questionnaire completed by 10 recruiting centres.
Question
Database Access
Did you find that the instructions provided for accessing the database were easy to f
Did you encounter any difficulties in accessing the database?
Were any issues raised regarding access to the database resolved efficiently and effec
Image Quality
How did the image quality compare to what you are used to?
Did you think the image quality was sufficient to complete the plan of the day asses
Timings
Approximately how long did you spend working through the guidance example case
Approximately how long did it take you to complete the assessment?
PoD Confidence
Do you feel that the guidance cases provided good examples of how to implement th
Do you think that completing the guidance cases increased your confidence in plan s
Do you feel that the guidance and assessment has prepared you for plan selection wexperiences with the assessment and PoD selection. This question-
naire included questions on database accessibility, image quality,
timings and PoD confidence (Table 1).
2.5. Retrospective review for first patient recruited at each centre
In order to ensure accuracy of PoD selection on-trial, the plan-
ning CT data and all six weekly CBCT were collected from each cen-
tre for their first HYBRID patient. The CBCTs acquired for each
patient were evaluated by three QA reviewers and a consensus
PoD decided for each treatment fraction. The reviewers PoD deci-
sion was compared with the PoD selected by the centre and any
discrepancies reported.3. Results
3.1. Pre-accrual PoD assessment results
The PoD guidance and assessment module was completed by 71
RTTs from 10 recruiting centres. As specified in the trial protocol,
the PoD selection required the smallest possible PTV contour from
the three available plans to cover the bladder volume with a 3 mm
internal margin at each assessment case. The median assessment
score for all individuals was 92% (Range: 58–100%) with 56/71
(79%) RTTs achieving the required pass mark on first attempt at
the assessment (Fig. 2). The 15 (21%) individuals who did not pass
on their first attempt were asked to repeat the same assessment
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knowledge of pelvic anatomy, PTV margin concepts used in the
trial, and the trial protocol requirements on PoD plan selections.
The required concordance was achieved by 12/15 RTTs on their
second attempt, with a median pass rate of 92%. The assessment
was discussed via a webinar with the remaining individuals andFig. 2. A bar chart illustrating RTTs scores for first attempt at assessment.
Fig. 3. A bar chart summarising the agreement with expert answers for each
assessment CBCT. CBCT 1–6 represent the female CBCT cases and 7–12 represent
the male CBCT cases.
Fig. 4. A boxplot graph describing thethey were subsequently QA approved during a RTTQA centre visit
for their first patient recruited to HYBRID.
Fig. 3 shows the agreement with the expert consensus answers
for each of the 12 assessment CBCT images (1–6 for the female
assessment CBCT and 7–12 for the male assessment CBCT). Of
the 852 total PoD selections, 751 (88%) answers agreed with the
expert answer. For the PoD selections which disagreed with the
expert consensus answer, no more than one size away in PTV
was chosen eg medium PTV was chosen when the small PTV was
the correct PoD answer. For CBCT where the expert consensus
answer was medium, smaller PTVs were selected for 3% and 10%
and larger PTVs were selected for 14% and <1% of female and male
CBCTs respectively. Significantly different median scores (p < 0.05)
were attained for the male PoD assessment (median = 100%, range
50–100%) than for the female PoD assessment (median = 83%,
range 33–100%). As shown in the Fig. 4 box plot graph, when sep-
arating RTTs by staff grading, no significant difference in the med-
ian scores (p = 0.51) were seen between junior (AFC Band 5 & 6),
senior (AFC Band 7) and managerial (AFC Band 8) staff.
3.2. Questionnaire results
The online questionnaire was completed by all 10 recruiting
centres (Table 1). Users found the documentation provided to
access the database was clear and easy to follow. Due to the level
of IT security at recruiting centres, 6/9 centres encountered initial
difficulties with remotely accessing the imaging databases, how-
ever all centres reported issues with access were resolved effec-
tively and efficiently. Image quality was reported to be of
sufficient quality to confidently complete the PoD assessment by
9/10 centres, with 7/10 centres reporting the images to be a similar
quality to the CBCT images generated locally. The POD guidance
and assessment module was completed by the majority of centres
is less than 2 h.
All respondents reported the PoD guidance and assessment
module prepared them for PoD selection within the trial. 5/8 cen-
tres felt the guidance cases provided good examples of PoD selec-
tion with 3/8 stating either there was not enough variation in PTV
sizes across the guidance cases or that not enough information was
provided regarding why certain PTVs were chosen. Despite this,
6/8 respondents thought the guidance cases increased their PoDassessment scores per AFC band.
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already experienced in reviewing bladder patients and the guid-
ance cases provided a good reminder of the protocol requirements.3.3. First recruited patient concordance results
The PoD decisions for the first HYBRID patient recruited at each
of the 10 participating centres, giving a total of 60 treatment frac-
tions, were retrospectively reviewed. For 51/60 (85%) treatment
fractions the PoD selected by the recruiting centre agreed with
the consensus PoD decided by the QA reviewers. Of the remaining
9 treatment fractions, the PoD chosen by the recruiting centre was
always larger than that chosen by the reviewers. It is suggested
that there was a tendency for participating centres to be more cau-
tious in their approach to PoD selection. There were no treatment
fractions where the PoD decision varied by more than one PTV size
between the QA reviewers and recruiting centre.4. Discussion
This study describes the implementation of remote access
image databases for individual staff assessment in adaptive blad-
der RT plan selection as part of a multi-centre randomised trial
QA programme. Whilst QA exercises such as the facility question-
naire, external reference dosimetry checks, and benchmark delin-
eation and planning cases have been widely adopted by most
international trials groups, QA of the IGRT and treatment verifica-
tion component of a trial remains uncommon [12,13]. IGRT QA
across multiple recruiting centres as part of a clinical trial presents
several challenges including accommodating different vendors’
equipment, different levels of staff experience and departmental
protocols including features such as action thresholds [15].
For single centre clinical trials workshop based training has
proved successful however this is likely to be difficult to orches-
trate in a multi-centre clinical trial setting [5,6]. Multicentre pre-
accrual IGRT credentialing has been attempted by other interna-
tional QA groups [14,15]. Middleton et al undertook a series of
IGRT credentialing site visits using a laptop with Varian offline
review package to prospectively review the image matching of
fiducial markers in prostate patients. Each centre had a junior
and senior RTT complete 39 image registrations and then the
match data was exported for analysis. The authors noted that the
ultimate goal would be to achieve a vendor independent web
based system allowing credentialing of all RTTs rather than only
a subset in a larger clinical trial setting [15].
As part of the BOLART adaptive bladder trial IGRT credentialing
was implemented using a web based e-learning programme and
on-line plan selection using phantoms to assess adherence to pro-
tocol. The BOLART programme, whilst being easy to use and signif-
icantly improving protocol knowledge provided limited practical
experience for appropriate PoD selection [9]. The phantom studies
do provide practical experience but do not easily demonstrate the
image artefacts and bladder deformation caused by physiological
changes in real patient cases, and the challenges of 3D image reg-
istration within vendor-specific systems [16].
A novel process for pre-accrual QA assessment of RTT compe-
tency in PoD selection has been developed and implemented in
HYBRID. The process considers vendor specific user requirements,
incorporates the complexity of real patient CBCT images and
allows geographically diverse remote access across the UK provid-
ing a time efficient approach for IGRT training and QA assessment.
The PoD assessment results from multiple RTTs across several
recruiting centres demonstrated similar results to locally imple-
mented programmes [6]. A median pass mark of 92% was attained,
with 79% of staff achieving the required pass mark on the firstattempt. The questionnaire feedback confirmed the guidance and
assessment increased confidence and prepared staff for PoD selec-
tion within the HYBRID trial. There was a good agreement reported
between the PoD selected by centres and PoD chosen by QA
reviewers for the first patient recruited from each site.
The grade and number of staff undertaking the plan selection
assessment was determined by each individual centre. In our study
the grade of a staff member did not affect the pass mark achieved
in the assessment. This shows that the PoD guidance and assess-
ment module provided good comprehensive instructions and
allowed each staff member, regardless of experience, to under-
stand and implement the trial protocol. This finding is consistent
with Middleton et al who reported uniform matching of fiducial
markers across recruiting centres regardless of experience of the
observer (junior vs senior RTT) for QA accreditation for the 08.01
PROFIT trial [15].
Our study suggested that assessment scores were lower on
average for the female PoD assessment CBCT than the male PoD
assessment CBCT. Also of those answers that did not agree with
the expert answer, the majority of incorrect answers were larger
for the female assessment CBCT and smaller for the male assess-
ment CBCT. It is acknowledged that as only a single male and
female case was used within this assessment it is difficult to draw
any conclusions from this. Female and male cases were selected for
the assessment to reflect the difference in patient’s anatomy that
would be encountered in the trial.
The web-based PoD guidance and assessment module was not
without limitations. In the online questionnaire staff commented
that the guidance cases required a more in-depth explanation of
isocentre corrections applied and why certain PoD decisions were
made. The PoD guidance document has been updated accordingly
for future RTT training. As this was the first web based assessment
module of its kind undertaken by the RTTQA group, there were
some initial issues with accessing the remote databases due to
security restriction employed by individual recruiting centres’ IT
departments. These issues were dealt with in a timely manner
and future web based systems will need to take hospital IT security
issues into consideration in the early conception phase.5. Conclusion
The PoD pre-accrual guidance and assessment module was suc-
cessfully implemented which enabled RTTs from HYBRID partici-
pating centres to access and utilise CBCT data using a vendor
specific system. It is suggested that the module increases operator
knowledge and confidence when selecting the PoD within the clin-
ical trial. This novel approach can be utilised in future clinical trials
which require QA of PoD selection.
Declaration of Competing Interest
The authors declare that they have no known competing finan-
cial interests or personal relationships that could have appeared
to influence the work reported in this paper.
Acknowledgements
HYBRID is funded by Cancer Research UK (CRUK/12/055) and
coordinated by the Cancer Research UK funded Clinical Trials and
Statistics Unit at the Institute of Cancer Research (ICR-CTSU). The
ICR-CTSU is supported by the Cancer Research UK (CRUK) core
grant (Grant number C1491/A15955). The authors would like to
thank Royal Marsden Hospital and Clatterbridge Cancer Centre
staff teams for hosting the image databases and all RTTs that
undertook the guidance and assessment module.
32 E. Patel et al. / Clinical and Translational Radiation Oncology 19 (2019) 27–32References
[1] Tsang Y, Baker A, Patel E, Miles E. A new era for clinical trial quality assurance:
a credentialing programme for RTT led adaptive radiotherapy. Tech
Innovations Patient Supp Radiat Oncol 2018;5:1–2.
[2] Huddart R, McDonald F, Lewis R, Hall E. HYBRID – evaluating new radiation
technologies in patients with unmet needs. Clin Oncol 2013;25:546–8.
[3] Collins SD, Leech MM. A review of plan library approaches in adaptive
radiotherapy of bladder cancer. Acta Oncol 2018;57(5):566–73. https://doi.
org/10.1080/0284186X.2017.1420908.
[4] Kong V, Taylor A, Rosewall T. Adaptive radiotherapy for bladder cancer – a
systematic review. J Med Imaging Radiat Sci 2017;48(2):199–206.
[5] Foroudi F, Wong J, Kron T, et al. Development and evaluation of a training
program for therapeutic RTTs as a basis for online adaptive radiation therapy
for bladder carcinoma. Radiography 2010;16:14–20.
[6] McNair HA, Hafeez S, Taylor H, et al. RTT-led plan selection for bladder cancer
radiotherapy: initiating a training programme and maintaining competency.
Br J Radiol 2015;88:20140690.
[7] McDonald F, Lalondrelle S, Taylor H, et al. Clinical implementation of adaptive
hypofractionated bladder radiotherapy for improvement in normal tissue
irradiation. Clin Oncol 2013;25:549–56.
[8] Vestergaard A, Muren LP, Lindberg H, et al. Normal tissue sparing in a phase II
trials on daily adaptive plan selection in radiotherapy for urinary bladder
cancer. Acta Oncol 2014;53:997–1004.
[9] Foroudi F, Pham D, Bressel M, et al. The Utility of e-learning to support training
for a multi-centre bladder online adaptive radiotherapy trial (TROG 10.01 –
BOLART). Radiother Oncol 2013;109:165–9.[10] Pham D, Roxby P, Kron T, Rolfo A, Foroudi F. Introduction of online adaptive
radiotherapy for bladder cancer through a multicentre clinical trial (Trans-
Tasman Radiation Oncology Group 10.01): lessons learned. J Med Phys
2013;38(2):59–66.
[11] Lalondrelle S, Huddart D, Warren-Oseni K, et al. Adaptive-predictive organ
localisation using cone-beam computed tomography for improved accuracy in
external beam radiotherapy for bladder cancer. Int J Radiat Oncol Biol Phys
2011;79(3):705–12.
[12] Weber DC, Poortmans PMP, Hurkmans CW, Aird E, Gulyban A, Fairchild A.
Quality assurance for prospective EORTC radiation oncology trials: the
challenges of advances technology in a multicentre international setting.
Radiother Oncol 2011;100:150–6.
[13] Fitzgerald TJ, Bishop-Jodoin M, Bosch WR, et al. Future vision for the quality
assurance of oncology clinical trials. Front Oncol 2013;3:1–10.
[14] Cui Y, Galvin JM, Straube WL, et al. Multi-system verification of registration for
image-guided radiotherapy in clinical trials. Int J Radiat Oncol Biol Phys
2011;81(1):305–12.
[15] Middleton M, Frantzis J, Healy B, et al. Successful implementation of image-
guided radiation therapy quality assurance in the Trans Tasman radiation
oncology group 08.01 PROFIT Study. Int J Radiat Oncol Biol Phys 2011;81
(5):1576–81.
[16] Kron T, Pham D, Roxby P, et al. Credentialing of radiotherapy centres for a
clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01).
Radiother Oncol 2012;103:293–8.
